![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print July 1, 2005
Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599
Corresponding Author: hke{at}med.unc.edu
Phosphodiesterase (PDE) inhibitors have been widely studied as therapeutics for treatment of human diseases. However, the mechanism by which each PDE family recognizes selectively a category of inhibitors remains a puzzle. Here we report the crystal structure of PDE7A1 catalytic domain in complex with non-selective inhibitor 3-isobutyl-1-methylxanthine and kinetic analysis on the mutants of PDE7A1 and PDE4D2. Our studies suggest at least three elements playing critical roles in inhibitor selectivity: (1) the conformation and position of an invariant glutamine, (2) the natures of scaffolding residues, and (3) residues altering shape and size of the binding pocket. Kinetic analysis shows that single PDE7 to 4 mutations increase the sensitivity of PDE7 to PDE4 inhibitors, but are not sufficient to render the engineered enzymes comparable with the wild types. The triple S373Y/S377T/I412S mutation of PDE7A1 produces a PDE4-like enzyme, implying that multiple elements must work together to determine inhibitor selectivity.
J. Biol. Chem, 10.1074/jbc.M504398200
Submitted on April 21, 2005
Revised on June 23, 2005
Accepted on July 1, 2005
Multiple elements jointly determine inhibitor selectivity of cyclic nucleotide phosphodiesterases 4 and 7
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. Wang, Y. Liu, J. Hou, M. Zheng, H. Robinson, and H. Ke From the Cover: Structural insight into substrate specificity of phosphodiesterase 10 PNAS, April 3, 2007; 104(14): 5782 - 5787. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Bender and J. A. Beavo Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use Pharmacol. Rev., September 1, 2006; 58(3): 488 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang, Y. Liu, Q. Huai, J. Cai, R. Zoraghi, S. H. Francis, J. D. Corbin, H. Robinson, Z. Xin, G. Lin, et al. Multiple Conformations of Phosphodiesterase-5: IMPLICATIONS FOR ENZYME FUNCTION AND DRUG DEVELOPMENT J. Biol. Chem., July 28, 2006; 281(30): 21469 - 21479. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Han, P. Sonati, C. Rubin, and T. Michaeli PDE7A1, a cAMP-specific Phosphodiesterase, Inhibits cAMP-dependent Protein Kinase by a Direct Interaction with C J. Biol. Chem., June 2, 2006; 281(22): 15050 - 15057. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |